Safety study of ZE74-0282 in healthy adults
Part of Blood & lymphatic, Cancer clinical trials.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old and in generally good health
- Have a normal weight range (BMI 18–32, under 100 kg)
- Have normal heart function, blood pressure, and vital signs
- Not be pregnant, breastfeeding, or planning pregnancy during the study and for 30–90 days after
- Not take most medications, supplements, or vaccines in the weeks before and during the study
- Not have a history of serious illness, heart disease, or liver/kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a new medicine called ZP9830 to see if it is safe for people and how it works in the body. Healthy volunteers aged 18 to 45 can join.
This study tests a new medicine called ZL-1503 in healthy people to see how the body processes it and if it's safe. It helps doctors learn the right dose for future studies.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This early-stage trial tests a new oral drug (ZE66-0205) for the first time in healthy people to see how safe it is and how the body handles it. The results will guide future studies for patients.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.